Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 20;22(5):e1004590.
doi: 10.1371/journal.pmed.1004590. eCollection 2025 May.

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America

Sabine Naudin  1   2 Molin Wang  3   4   5 Niki Dimou  1 Elmira Ebrahimi  1 Jeanine Genkinger  6   7 Hans-Olov Adami  8   9 Demetrius Albanes  10 Ana Babic  11 Matt Barnett  12 David Bogumil  13 Hui Cai  14 Chu Chen  15 A Heather Eliassen  3   16 Jo L Freudenheim  17 Gretchen Gierach  10 Edward L Giovannucci  3   16 Marc J Gunter  1 Niclas Håkansson  18 Mayo Hirabayashi  19 Tao Hou  16 Brian Z Huang  13 Wen-Yi Huang  10 Harindra Jayasekara  20   21   22 Michael E Jones  23 Verena A Katzke  24 Woon-Puay Koh  25   26 James V Lacey  27 Ylva Trolle Lagerros  28   29 Susanna C Larsson  18 Linda M Liao  10 Kenneth Lo  30 Erikka Loftfield  10 Robert J MacInnis  20   21 Satu Männistö  31 Marjorie L McCullough  32 Anthony Miller  33 Roger L Milne  20   21   34 Steven C Moore  10 Lorelei A Mucci  3   35 Marian L Neuhouser  12 Alpa V Patel  32 Elizabeth A Platz  36   37 Anna Prizment  38 Kim Robien  39 Thomas E Rohan  40 Carlotta Sacerdote  41 Sven Sandin  8   42   43 Norie Sawada  44 Minouk Schoemaker  45 Xiao-Ou Shu  14 Rashmi Sinha  10 Linda Snetselaar  46 Meir J Stampfer  3   16   5 Rachael Stolzenberg-Solomon  10 Cynthia A Thomson  47 Anne Tjønneland  48 Caroline Y Um  32 Piet A van den Brandt  49 Kala Visvanathan  36   37 Sophia S Wang  27 Renwei Wang  50 Elisabete Weiderpass  1 Stephanie J Weinstein  10 Emily White  51 Walter Willett  3   16 Alicja Woslk  18 Brian M Wolpin  11   5 Shiaw-Shyuan S Yaun  16 Chen Yuan  11 Jian-Min Yuan  50   52 Wei Zheng  14 Paul Brennan  1 Stephanie A Smith-Warner  3   16 Pietro Ferrari  1
Affiliations

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America

Sabine Naudin et al. PLoS Med. .

Abstract

Background: Alcohol is a known carcinogen, yet the evidence for an association with pancreatic cancer risk is considered as limited or inconclusive by international expert panels. We examined the association between alcohol intake and pancreatic cancer risk in a large consortium of prospective studies.

Methods and findings: Population-based individual-level data was pooled from 30 cohorts across four continents, including Asia, Australia, Europe, and North America. A total of 2,494,432 participants without cancer at baseline (62% women, 84% European ancestries, 70% alcohol drinkers [alcohol intake ≥ 0.1 g/day], 47% never smokers) were recruited between 1980 and 2013 at the median age of 57 years and 10,067 incident pancreatic cancer cases were recorded. In age- and sex-stratified Cox proportional hazards models adjusted for smoking history, diabetes status, body mass index, height, education, race and ethnicity, and physical activity, pancreatic cancer hazard ratios (HR) and 95% confidence intervals (CI) were estimated for categories of alcohol intake and in continuous for a 10 g/day increase. Potential heterogeneity by sex, smoking status, geographic regions, and type of alcoholic beverage was investigated. Alcohol intake was positively associated with pancreatic cancer risk, with HR30-to-<60 g/day and HR≥60 g/day equal to 1.12 (95% CI [1.03,1.21]) and 1.32 (95% CI [1.18,1.47]), respectively, compared to intake of 0.1 to <5 g/day. A 10 g/day increment of alcohol intake was associated with a 3% increased pancreatic cancer risk overall (HR: 1.03; 95% CI [1.02,1.04]; pvalue < 0.001) and among never smokers (HR: 1.03; 95% CI [1.01,1.06]; pvalue = 0.006), with no evidence of heterogeneity by sex (pheterogeneity = 0.274) or smoking status (pheterogeneity = 0.624). Associations were consistent in Europe-Australia (HR10 g/day = 1.03, 95% CI [1.00,1.05]; pvalue = 0.042) and North America (HR10 g/day = 1.03, 95% CI [1.02,1.05]; pvalue < 0.001), while no association was observed in cohorts from Asia (HR10 g/day = 1.00, 95% CI [0.96,1.03]; pvalue = 0.800; pheterogeneity = 0.003). Positive associations with pancreatic cancer risk were found for alcohol intake from beer (HR10 g/day = 1.02, 95% CI [1.00,1.04]; pvalue = 0.015) and spirits/liquor (HR10 g/day = 1.04, 95% CI [1.03,1.06]; pvalue < 0.001), but not wine (HR10 g/day = 1.00, 95% CI [0.98,1.03]; pvalue = 0.827). The differential associations across geographic regions and types of alcoholic beverages might reflect differences in drinking habits and deserve more investigations.

Conclusions: Findings from this large-scale pooled analysis support a modest positive association between alcohol intake and pancreatic cancer risk, irrespective of sex and smoking status. Associations were particularly evident for baseline alcohol intake of at least 15 g/day in women and 30 g/day in men.

PubMed Disclaimer

Conflict of interest statement

I have read the journal's policy and the authors of this manuscript have the following competing interests: MS is employed at IQVIA, a contract research company, and has no financial stake in the results of the current study. WZ and SCM are Academic Editors on PLOS Medicine's editorial board.

Figures

Fig 1
Fig 1. Association between alcohol intake and the risk of pancreatic cancer, overall and by sex.
Abbreviations: HR: hazard ratio, CI: confidence interval; 1 Cox proportional hazard models were adjusted for smoking status, smoking duration, smoking intensity, time since smoking cessation, diabetes status, body mass index, height, education, race and ethnicity, and physical activity. Analyses in continuous were further adjusted for an indicator variable for alcohol drinking status. Models were stratified by age at baseline, year of baseline questionnaire completion, study, country (in EPIC [59]), and sex (overall models only); 2 P-value for the Wald test statistics compared with a X2 distribution with degrees of freedom equal to the number of alcohol intake categories minus one, not including the category of non-drinkers (<0.1 g/day); 3 P-value for alcohol consumption modelled as a continuous variable for a 10 g/day increase, with inclusion in the model of an indicator variable expressing the alcohol drinking status; 4 Heterogeneity across studies was tested by adding interaction terms between alcohol intake modeled in continuous and each study level, then comparing the Wald test statistics for significance to a X2 distribution with the number of degrees of freedom equal to the number of studies minus one, in a model including an indicator variable expressing the alcohol drinking status; 5 Heterogeneity by sex was tested by adding interaction terms between alcohol intake modelled in continuous and sex, then comparing the Wald test statistics for significance to a X2 distribution with one degree of freedom, in a model including an indicator variable expressing the alcohol drinking status. The alcohol and pancreatic cancer dose–response relationship using restricted cubic splines among participants with alcohol intake lower than 100 g/day showed no departure from linearity, neither overall (pnonlinearity = 0.345) nor in women (pnonlinearity = 0.355) or men (pnonlinearity = 0.633) (Fig B in S1 File).
Fig 2
Fig 2. Association between alcohol intake and the risk of pancreatic cancer by smoking status (never, former, current smoker).
Abbreviations: HR: hazard ratio, CI: confidence interval; 1 ATBC recruited only current smokers; 2 Cox proportional hazard models were adjusted for smoking duration, smoking intensity, time since smoking cessation, diabetes status, body mass index, height, education, race and ethnicity and physical activity. Analyses in continuous were further adjusted for an indicator variable for alcohol drinking status. Models were stratified by age at baseline, year of baseline questionnaire completion, study, country (in EPIC [59]) and sex. Models included interaction terms between alcohol intake and smoking status, keeping the 0.1 to  <5 g/day category as reference, while participants without information on their smoking status were excluded; 3 P-value for the Wald test statistics compared with a X2 distribution with four degrees of freedom, not including the category of non-drinkers (<0.1 g/day); 4 P-value for alcohol consumption modelled in continuous, in a model including an indicator variable expressing alcohol drinking status; 5 Heterogeneity by smoking was tested comparing the Wald test statistics for interaction between alcohol intake and smoking level to a X2 distribution, with either four degrees of freedom not including the category of non-drinkers (<0.1 g/day) for analyses in categories, or one degree of freedom in a model including an indicator variable expressing alcohol drinking status for analyses in continuous.
Fig 3
Fig 3. Association between alcohol intake and the risk of pancreatic cancer by geographic region (Europe/Australia, North America, Asia).
Abbreviations: HR: hazard ratio, CI: confidence interval; 1 Geographic region was coded as Europe (ATBC, COSM, GS, EPIC, MCCS, NLCS, SMC, SNMC and WLHS), North America (BCDDP, CARET, CLUEII, CNBSS, CPSII, CTS, HPFS, IWHS, MEC, NHS, NHSII, NIH-AARP, NYSC, PLCO, VITAL, and WHI) and Asia (JPHCI, JPHCII, SCHS, SCS and SMHS); 2 Cox proportional hazard models were adjusted for smoking status, smoking duration, smoking intensity, time since smoking cessation, diabetes status, body mass index, height, education, race and ethnicity, and physical activity. Analyses in continuous were further adjusted for an indicator variable for alcohol drinking status. Models were stratified by age at baseline, year of baseline questionnaire completion, study, and country (in EPIC [59]) and sex; 3 For analyses in categories, p-value compared the Wald test statistics with a X2 distribution with degrees of freedom equal to the number of alcohol intake categories minus one, not including the category of non-drinkers (<0.1 g/day). In continuous analyses, it was the p-value for alcohol consumption in continuous in a model including an indicator variable expressing alcohol drinking status; 4 Heterogeneity across studies within each geographic region was tested adding interaction terms between alcohol intake modelled in continuous and each study level, then comparing the Wald test statistics for significance to a X2 distribution with the number of degrees of freedom equal to the number of studies minus one, in a model including an indicator variable expressing alcohol drinking status; 5 Heterogeneity by sex within each geographic region was tested adding interaction terms between alcohol intake in continuous and sex, then comparing the Wald test statistics for significance to a X2 distribution with one degree of freedom in a model including an indicator variable expressing alcohol drinking status; 6 Heterogeneity by geographic region was tested adding interaction terms between alcohol intake in continuous and geographic region, then comparing the Wald test statistics for significance to a X2 distribution with two degrees of freedom in a model including an indicator variable expressing alcohol drinking status.
Fig 4
Fig 4. Association between alcohol intake from different alcoholic beverages and the risk of pancreatic cancer.
Abbreviations: HR: hazard ratio, CI: confidence interval; 1 Information on type of alcoholic beverages was not available in NYSC; 2 Cox proportional hazard models were adjusted for alcohol intake from the other type of beverage than the one under evaluation, smoking status, smoking duration, smoking intensity, time since smoking cessation, diabetes status, body mass index, height, education, race and ethnicity, and physical activity. Analyses in continuous were further adjusted for an indicator variable for alcohol drinking status based on total alcohol intake. Models were stratified by age at baseline, year of baseline questionnaire completion, cohort and country (in EPIC [59]) and sex; 3 For analyses in categories, pWald compared the Wald test statistics with a X2 distribution with degrees of freedom equal to the number of the given type of beverage categories minus one, not including the category of non-drinkers (<0.1 g/day); 4 In continuous analyses, ptrend was the p-value for the given type of beverage modelled as a continuous variable for a 10 g/day increase, in a model including an indicator variable expressing alcohol drinking status; 5 Heterogeneity across studies for a given type of beverage was tested adding interaction terms between the given type of beverage modeled in continuous and each study level, then comparing the Wald test statistics for significance to a X2 distribution with the number of degrees of freedom equal to the number of studies minus one, in a model including an indicator variable expressing alcohol drinking status; 6 Heterogeneity by geographic region for a given type of beverage was tested adding interaction terms between the type of beverage and geographic region, then comparing the Wald test statistics for significance to a X2 distribution with two degrees of freedom, in a model including an indicator variable expressing alcohol drinking status; 7 Heterogeneity by sex for each type of alcoholic beverage was tested adding interaction terms between alcohol intake and sex, then comparing the Wald test statistics for significance to a X2 distribution with one degree of freedom, in a model including an indicator variable expressing alcohol drinking status.

Comment in

References

    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. - PubMed
    1. Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM-L, Myklebust TÅ, et al.. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–505. doi: 10.1016/S1470-2045(19)30456-5 . - DOI - PMC - PubMed
    1. Cabasag C, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. Br J Cancer. 2022. - PMC - PubMed
    1. Cabasag CJ, Ferlay J, Laversanne M, Vignat J, Weber A, Soerjomataram I. Pancreatic cancer: an increasing global public health concern. Gut. 2021. - PubMed
    1. Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021. - PMC - PubMed